Due to a production error, there was a mistake in Figure 1 as published. Figure 1B is supposed to be Figure 1C and Figure 1C is supposed to be Figure 1B.
The correct figure appears below:
Figure 1
The publisher apologizes for this mistake. The original article has been updated.
Summary
Keywords
Alzheimer's disease, fasudil, PS19, P301S, tau, proteomic
Citation
Frontiers Production Office (2024) Erratum: Effect of the ROCK inhibitor fasudil on the brain proteomic profile in the tau transgenic mouse model of Alzheimer's disease. Front. Aging Neurosci. 16:1409164. doi: 10.3389/fnagi.2024.1409164
Received
29 March 2024
Accepted
29 March 2024
Published
10 April 2024
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
16 - 2024
Updates
Copyright
© 2024 Frontiers Production Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office production.office@frontiersin.org
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.